Literature DB >> 15099627

Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs.

Wolf Drescher1, Karen P Weigert, Mathias H Bünger, Jørgen Ingerslev, Cody Bünger, Ebbe S Hansen.   

Abstract

The pathogenesis of corticosteroid-induced femoral head necrosis is assumed to be ischemia. The purpose of this study was to investigate the perfusion pattern of the femoral head and plasma coagulability during 24 h corticosteroid megadose treatment, as recommended by the National Acute Spinal Cord Injury Studies (NASCIS), in the awake big animal model. Blindedly, 9 animals underwent megadose methylprednisolone infusion (30 mg/kg intravenously as an initial bolus, followed by 5.4 mg/kg/h for further 23 h) while 9 animals served as placebo treated controls. Regional blood flow of the systematically subdivided femoral head, proximal femur, acetabulum, and soft tissue hip regions was investigated by the microsphere technique at steady state (phase 1), after the initial bolus infusion (phase 2), and after the completed treatment (phase 3). Plasma coagulability was examined in phases 1 and 3. Blood flow of the femoral head epiphysis and metaphyseal cancellous bone was unchanged after one hour of steroid infusion, but decreased after the completed treatment at 24 h in the experimental group. Femoral head blood flow reduction was global without a tendency to more pronounced blood flow decrease in any subregion. Plasma fibrinogen was significantly higher after 24 h of steroid infusion than in the placebo control group. 24 h high dose methylprednisolone treatment causes femoral head blood flow reduction and hypercoagulability of plasma in the normal awake immature pig. These findings may be pathogenetic factors in the early stage of steroid-induced osteonecrosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099627     DOI: 10.1016/j.orthres.2003.10.002

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  27 in total

1.  Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.

Authors:  Salvatore Ruggiero; Julie Gralow; Robert E Marx; Ana O Hoff; Mark M Schubert; Joseph M Huryn; Bela Toth; Kathryn Damato; Vicente Valero
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

2.  Electromagnetic fields: a novel prophylaxis for steroid-induced osteonecrosis.

Authors:  Masashi Ishida; Mikihiro Fujioka; Kenji A Takahashi; Yuji Arai; Toshikazu Kubo
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

3.  Association of toll-like receptor 4 signaling pathway with steroid-induced femoral head osteonecrosis in rats.

Authors:  Lei Tian; Dong-Sheng Zhou; Kun-Zheng Wang; Wei Zhang; Zhi-Bin Shi; Li-Hong Fan; Shui Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

4.  To investigate the role of the nervous system of bone in steroid-induced osteonecrosis in rabbits.

Authors:  L Wang; N Wang; M Li; K Wang
Journal:  Osteoporos Int       Date:  2010-03-04       Impact factor: 4.507

5.  Osteonecrosis of the femoral head: An update in year 2012.

Authors:  Anjan P Kaushik; Anusuya Das; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

6.  Effects of glucocorticoid on adipocyte size in human bone marrow.

Authors:  Masaru Kitajima; Masamori Shigematsu; Kenji Ogawa; Hajime Sugihara; Takao Hotokebuchi
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

Review 7.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

8.  Vitamin E prevents steroid-induced osteonecrosis in rabbits.

Authors:  Masaaki Kuribayashi; Mikihiro Fujioka; Kenji A Takahashi; Yuji Arai; Masashi Ishida; Tsuyoshi Goto; Toshikazu Kubo
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

9.  Multifocal osteonecrosis related to corticosteroid: ten years later, risk of progression and observation of subsequent new osteonecroses.

Authors:  Charles-Henri Flouzat-Lachaniette; François Roubineau; Clemence Heyberger; Charlie Bouthors; Philippe Hernigou
Journal:  Int Orthop       Date:  2015-12-03       Impact factor: 3.075

10.  Cerebral venous thrombosis after high dose steroid in multiple sclerosis: a case report.

Authors:  S Gazioglu; D Solmaz; C Boz
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.